BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9241106)

  • 1. Spontaneous reports of psychiatric adverse effects to mefloquine in the Netherlands.
    van Riemsdijk MM; van der Klauw MM; Pepplinkhuizen L; Stricker BH
    Br J Clin Pharmacol; 1997 Jul; 44(1):105-6. PubMed ID: 9241106
    [No Abstract]   [Full Text] [Related]  

  • 2. [Convulsions during prophylactic use of mefloquine].
    Heeringa M; Kuster JA; Meyboom RH; Bouvy M
    Ned Tijdschr Geneeskd; 1998 Nov; 142(45):2477-80. PubMed ID: 10028330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mefloquine--a brief review.
    Ruff T
    Aust Fam Physician; 1996 May; 25(5):793. PubMed ID: 8935556
    [No Abstract]   [Full Text] [Related]  

  • 4. An antimalarial malady.
    Baker PG
    Aust Fam Physician; 1996 May; 25(5):791. PubMed ID: 8935555
    [No Abstract]   [Full Text] [Related]  

  • 5. The Lariam debate.
    Eaton L
    Nurs Times; 1997 Jun 25-Jul 1; 93(26):43. PubMed ID: 9239057
    [No Abstract]   [Full Text] [Related]  

  • 6. [Mefloquine: neuropsychiatric adverse effects are often severe and persistent long after withdrawal of the drug].
    Jensen JJ
    Ugeskr Laeger; 1998 Apr; 160(16):2413. PubMed ID: 9616091
    [No Abstract]   [Full Text] [Related]  

  • 7. Mefloquine prophylaxis: an overview of spontaneous reports of severe psychiatric reactions and convulsions.
    Bem JL; Kerr L; Stuerchler D
    J Trop Med Hyg; 1992 Jun; 95(3):167-79. PubMed ID: 1597872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mefloquine-induced eosinophilic pneumonia.
    Katsenos S; Psathakis K; Nikolopoulou MI; Constantopoulos SH
    Pharmacotherapy; 2007 Dec; 27(12):1767-71. PubMed ID: 18041895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mefloquine-induced pneumonitis.
    Soentjens P; Delanote M; Van Gompel A
    J Travel Med; 2006; 13(3):172-4. PubMed ID: 16706949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombotic-thrombocytopenic purpura following malaria prophylaxis with mefloquine.
    Fiaccadori E; Maggiore U; Rotelli C; Giacosa R; Parenti E; Cabassi A; Ariya K; Wirote L
    J Antimicrob Chemother; 2006 Jan; 57(1):160-1. PubMed ID: 16286357
    [No Abstract]   [Full Text] [Related]  

  • 11. Paranoid psychosis related to mefloquine antimalarial prophylaxis.
    Fuller SJ; Naraqi S; Gilessi G
    P N G Med J; 2002; 45(3-4):219-21. PubMed ID: 12968793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mefloquine induced grand mal seizure in a case of uncomplicated falciparum malaria.
    Garg MR; Gopinathan N; Kshirsagar NA
    J Assoc Physicians India; 1996 Oct; 44(10):750. PubMed ID: 9251361
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute and long-term psychiatric side effects of mefloquine: a follow-up on Danish adverse event reports.
    Ringqvist Å; Bech P; Glenthøj B; Petersen E
    Travel Med Infect Dis; 2015; 13(1):80-8. PubMed ID: 25435322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neuropsychiatric side effects of malarial prophylaxis with mefloquine (Lariam)].
    Minei-Rachmilewitz T
    Harefuah; 1999 Jul; 137(1-2):25-7, 87. PubMed ID: 10959270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mefloquine use and hospitalizations among US service members, 2002-2004.
    Wells TS; Smith TC; Smith B; Wang LZ; Hansen CJ; Reed RJ; Goldfinger WE; Corbeil TE; Spooner CN; Ryan MA
    Am J Trop Med Hyg; 2006 May; 74(5):744-9. PubMed ID: 16687673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mefloquine versus 3-day oral quinine-clindamycin in uncomplicated imported falciparum malaria.
    Ranque S; Parola P; Adehossi E; Brouqui P; Delmont J
    Travel Med Infect Dis; 2007 Sep; 5(5):306-9. PubMed ID: 17870636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Six-years monitoring the efficacy of the combination of artesunate and mefloquine for the treatment of uncomplicated falciparum malaria.
    Wattanakoon Y; Chittamas S; Pornkulprasit V; Kanda T; Thimasarn K; Rojanawatsirivej C; Looareesuwan S; Bunnag D
    Southeast Asian J Trop Med Public Health; 2003 Sep; 34(3):542-5. PubMed ID: 15115124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Severe neuropsychiatric reaction following mefloquine use].
    Gascón J; Almeda J; Corominas N; Corachán M
    Med Clin (Barc); 1993 Oct; 101(13):515-6. PubMed ID: 7741814
    [No Abstract]   [Full Text] [Related]  

  • 19. Lariam's legacy.
    Consum Rep; 2002 Mar; 67(3):60-1. PubMed ID: 11863012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adverse effects associated with antimalarial chemoprophylaxis].
    Corominas N; Gascón J; Mejías T; Caparrós F; Quintó L; Codina C; Ribas J; Corachán M
    Med Clin (Barc); 1997 May; 108(20):772-5. PubMed ID: 9265081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.